|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61P 9/04 | (2006.01) |
| (11) | Number of the document | 3645002 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18745732.0 |
| Date of filing the European patent application | 2018-06-29 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-30 |
| (46) | Date of publication of the claims translation | 2025-02-10 |
| (86) | Number | PCT/US2018/040181 |
| Date | 2018-06-29 |
| (87) | Number | WO 2019/006235 |
| Date | 2019-01-03 |
| (30) | Number | Date | Country code |
| 201762527983 P | 2017-06-30 | US |
| (72) |
HONARPOUR, Narimon , US
MALIK, Fady , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
Cytokinetics, Inc. , 350 Oyster Point Blvd, South San Francisco CA 94080, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Širdies nepakankamumo gydymo būdas širdies sarkomerų aktyvatoriais |
| METHODS OF TREATING HEART FAILURE WITH CARDIAC SARCOMERE ACTIVATORS |
| Payment date | Validity (years) | Amount | |
| 2025-05-27 | 8 | 185.00 EUR |
| 2026-06-29 |